Micron's Stock Is Up Over 270% This Year. Here's How It Can Still Double in 2026.

Micron is benefiting from a severe DRAM and NAND shortage tied to AI-driven data center demand, with the stock already up over 270% and trading at 18x forward earnings. The article argues Micron could potentially double again if 2027 demand and revenue growth exceed current estimates, which call for 263% next-quarter growth and 60% fiscal 2027 growth. New capacity from Micron's Idaho facility and other sites may not come online until mid-2027, supporting pricing power in the meantime.

Analysis

The market is pricing Micron as a cyclical beneficiary of a shortage, but the deeper setup is a multi-year capacity bottleneck across the entire memory stack. The second-order effect is that hyperscaler capex is no longer just an AI compute story; it is also becoming an upstream inventory-and-tooling story, which tends to keep memory pricing elevated longer than consensus expects. That supports near-term earnings revisions for MU, but it also means the equity is increasingly a reflexive trade on 2027 supply visibility rather than just spot pricing.

The key miss in consensus is that supply relief is slow even when producers spend aggressively: fabs take time, yields ramp unevenly, and any incremental capacity gets absorbed by AI demand before it can normalize pricing. That makes the base case for a sharp mean reversion weak over the next 12-18 months. The more important risk is not a demand collapse but a normalization of investor expectations: if the market decides that 2027 growth is already fully discounted, MU can de-rate even while fundamentals stay strong.

Relative value still looks more interesting than outright direction. MU is cheaper than the market’s preferred memory proxy, which suggests the crowd is paying up for visible scarcity while underestimating the operating leverage if estimates keep moving higher. A better contrarian expression may be to own MU against a basket of higher-multiple beneficiaries that require flawless execution, while using options to capture estimate-upgrade convexity into the next two reporting cycles.

Key Decisions for Investors

• Long MU vs SNDK pair: initiate 6-12 month market-neutral spread with MU on the long side and SNDK short. Thesis: MU has more embedded estimate-upgrade optionality at a lower multiple, while SNDK already prices in a larger share of the shortage narrative. Risk: if memory tightness persists but SNDK execution surprises, the spread can widen against us; keep stop-loss discipline on relative P/E premium expansion.
• Buy MU calls into the next earnings print: use 3-6 month calls or call spreads to express upside from guidance revision rather than chasing spot equity. Best risk/reward is in a call spread that benefits if fiscal 2027 growth expectations get reset higher over the next two quarters.
• Add NVDA only on weakness, not on the memory thesis: treat this as a separate AI capex beneficiary, but avoid paying for a second-order semiconductor rerating here. If the market starts to link data-center buildouts to broader component shortages, NVDA should outperform on the capex narrative, but the upside is likely less convex than MU in the near term.
• Avoid shorting MU outright for the next 2-3 quarters: supply normalization is too slow and earnings revisions can outrun valuation compression. If you need downside exposure, use a put spread funded by a short-dated call sale to target a de-rating only if data-center capex orders visibly slow.
• Watch for a 2027 capex read-through trade: if hyperscaler spending guides up again, add MU on any post-earnings pullback. The asymmetry favors buying dips until the market sees credible evidence of multi-quarter supply relief.